- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04911036
Study of the Effect of the Time of Diagnosis (Antenatal vs. Postnatal) on the Post-traumatic Reactions of Parents of Children Undergoing Oesophageal Atresia Surgery " (DANAO)
March 28, 2022 updated by: University Hospital, Lille
This is an observational, national multicentre (34 centres involved), cross-sectional study in psychology whose objective is to describe and compare the levels of post-traumatic reactions of mothers to the announcement of their child's EA diagnosis.
An ancillary study will be carried out among the fathers present who agree to participate in the study.
Study Overview
Study Type
Observational
Enrollment (Anticipated)
240
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Véronique Debarge, MD,PhD
- Phone Number: +33 0320445962
- Email: veronique.DEBARGE@chru-lille.fr
Study Locations
-
-
-
Lille, France, 59037
- Recruiting
- Hop Jeanne de Flandre Chu Lille
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Be a mother and/or a father of a living child aged between 12 and 24 months who has undergone neonatal surgery following a diagnosis of type 1 or type 3 EA
Description
Inclusion Criteria:
- Be the mother and/or a father of a living child aged 12 to 24 months who has undergone neonatal surgery following the diagnosis of type 1 or type 3 EA;
- Not to have objected to participating in the study (information and non-objection form signed by the investigator);
- To be socially insured.
Exclusion Criteria:
- Woman or man whose child with AO has a chromosomal abnormality;
- Woman or man whose child with AO has a polymalformative syndrome;
- Female or male minor ;
- Pregnant woman;
- Woman or man who does not speak French;
- Woman or man unable to consent, or benefiting from a legal protection regime (guardianship or curatorship);
- Woman or man deprived of liberty.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Mothers and/or fathers with an antenatal diagnosis
|
Perinatal PTSD Questionnaire State Trait Anxiety Inventory-forme Y-B Early Support Questionnaire Socio-demographic questionnaire
|
Mothers and/or fathers with a postnatal diagnosis
|
Perinatal PTSD Questionnaire State Trait Anxiety Inventory-forme Y-B Early Support Questionnaire Socio-demographic questionnaire
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perinatal Posttraumatic Stress Disorder Questionnaire (score PPQ)
Time Frame: at 2 months
|
The score PPQ derived from this instrument corresponds to the number of items (there are 14) to which the parent responded positively (theoretical spread: 0-14 points)
|
at 2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of mothers with Score PPQ >5
Time Frame: at 2 months
|
at 2 months
|
|
Questionnaire on early support
Time Frame: at 2 months
|
This is a questionnaire co-constructed with the Association Française de l'Atresie de l'œsophage (AFAO) to collect information on the perception of support available or received upon suspicion of an abnormality in the child.
It consists of 15 questions.
The first eight explore satisfaction with various aspects of early support (information, support, professionals met...).
The next seven address parental perceptions regarding information and support.
Most of the questions are to be answered on a 5-point Likert scale (e.g., from "Not at all satisfied" to "Very satisfied" or "Never" to "Almost always"), the other questions are closed-ended.
Time to complete the test: 5 to 10 minutes.
|
at 2 months
|
Correlation between STAI-Trait, Questionnaire on early support and Score PPQ evaluated to mothers
Time Frame: at 2 months
|
State-Trait Anxiety Inventory (STAI-TRAIT) SCORE: 20 items in the form of a 4-response Likert scale (from 1 : low anxiety to 4 : highest anxiety).
The score goes from 20 to 80 depending of the degree of anxiety.
|
at 2 months
|
Correlation between STAI-Trait, Questionnaire on early support and Score PPQ evaluated to fathers
Time Frame: at 2 months
|
at 2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Véronique Debarge, MD,PhD, University Hospital, Lille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 6, 2021
Primary Completion (Anticipated)
May 1, 2023
Study Completion (Anticipated)
May 1, 2023
Study Registration Dates
First Submitted
May 27, 2021
First Submitted That Met QC Criteria
May 27, 2021
First Posted (Actual)
June 2, 2021
Study Record Updates
Last Update Posted (Actual)
March 29, 2022
Last Update Submitted That Met QC Criteria
March 28, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019_26
- 2020-A00255-34 (Other Identifier: ID-RCB number,ANSM)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atresia, Esophageal
-
Meyer Children's Hospital IRCCSRecruiting
-
Zunyi Medical CollegeGuizhou Provincial People's Hospital; Binzhou Medical University; Union Hospital... and other collaboratorsActive, not recruitingCongenital Esophageal AtresiaChina
-
Birmingham Women's and Children's NHS Foundation...Not yet recruitingTracheo-Esophageal Fistula With Atresia of EsophagusUnited Kingdom
-
Cook Research IncorporatedCompletedDigestive System Abnormalities | Esophageal Atresia | Esophageal Disorders CongenitalUnited States, Canada
-
University Hospital, LilleInstitut National de la Santé Et de la Recherche Médicale, FranceRecruitingEsophageal AtresiaFrance
-
Boston Children's HospitalUnknown
-
Boston Children's HospitalWithdrawnEsophageal Atresia
-
Stanford UniversityThrasher Research FundCompletedEsophageal AtresiaUnited States
-
Medical University of GrazUnknownEsophageal AtresiaAustria
-
Xinhua Hospital, Shanghai Jiao Tong University...Unknown
Clinical Trials on Questionnaires
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Sun Yat-sen UniversityNot yet recruiting
-
Direction Centrale du Service de Santé des ArméesCompleted
-
Assistance Publique - Hôpitaux de ParisRecruitingIntensive Care Unit Syndrome | Pediatric Post-intensive Care SyndromeFrance
-
University Hospital, GrenobleUniversity Grenoble AlpsNot yet recruitingChildhood Cancer | Adapted Physical ActivityFrance
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Malignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
The University of Hong KongCompleted
-
Centre Hospitalier Universitaire DijonCompleted
-
UNC Lineberger Comprehensive Cancer CenterCompletedBreast Cancer | MetastasisUnited States
-
M.D. Anderson Cancer CenterTerminatedSkin CancerUnited States